104 related articles for article (PubMed ID: 1908389)
1. Effect of chronic ritanserin or clorgyline on amine and metabolite levels in rat frontal cortex.
Twist EC; Mitchell SN; Corn TH; Campbell IC
Eur J Pharmacol; 1991 Apr; 196(2):157-60. PubMed ID: 1908389
[TBL] [Abstract][Full Text] [Related]
2. The effect of chronic ritanserin and clorgyline administration on 5-HT2 receptor linked inositol phospholipid hydrolysis.
Twist EC; Brammer MJ; Stephenson JD; Corn TH; Campbell IC
Biochem Pharmacol; 1990 Nov; 40(9):2111-6. PubMed ID: 2122900
[TBL] [Abstract][Full Text] [Related]
3. 5HT2 receptor changes in rat cortex and platelets following chronic ritanserin and clorgyline administration.
Twist EC; Mitchell S; Brazell C; Stahl SM; Campbell IC
Biochem Pharmacol; 1990 Jan; 39(1):161-6. PubMed ID: 1688704
[TBL] [Abstract][Full Text] [Related]
4. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
Kato T; Dong B; Ishii K; Kinemuchi H
J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
[TBL] [Abstract][Full Text] [Related]
5. Chronic 5-HT2 receptor antagonist treatment alters 5-HT1A autoregulatory control of 5-HT release in rat brain in vivo.
Kidd EJ; Leysen JE; Marsden CA
J Neurosci Methods; 1990 Sep; 34(1-3):91-8. PubMed ID: 1701842
[TBL] [Abstract][Full Text] [Related]
6. Ethanol concentration induces production of 3,4-dihydroxyphenylacetic acid and homovanillic acid in mouse brain through activation of monoamine oxidase pathway.
Jamal M; Ito A; Miki T; Suzuki S; Ohta KI; Kinoshita H
Neurosci Lett; 2022 Jun; 782():136689. PubMed ID: 35598694
[TBL] [Abstract][Full Text] [Related]
7. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
Ballarín M; Carceller A; Guitart X
Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571
[TBL] [Abstract][Full Text] [Related]
8. Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain.
Waldmeier PC; Baumann PA
Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):20-6. PubMed ID: 6195533
[TBL] [Abstract][Full Text] [Related]
9. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
Garrett MC; Soares-da-Silva P
Neuropharmacology; 1990 Oct; 29(10):875-9. PubMed ID: 2123970
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of tryptamine receptors following chronic administration of clorgyline.
Martin LL; Neale RF; Wood PL
Brain Res; 1987 Sep; 419(1-2):239-43. PubMed ID: 3676728
[TBL] [Abstract][Full Text] [Related]
11. Reversibility of the interaction of CGP 11305 A with MAO A in vivo.
Waldmeier PC; Feldtrauer JJ; Stoecklin K; Paul E
Eur J Pharmacol; 1983 Oct; 94(1-2):101-8. PubMed ID: 6197309
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of clorgyline on catecholamine and indoleamine metabolites in the cerebrospinal fluid of rhesus monkeys.
Garrick NA; Scheinin M; Chang WH; Linnoila M; Murphy DL
Biochem Pharmacol; 1984 May; 33(9):1423-7. PubMed ID: 6203542
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
Hewton R; Salem A; Irvine RJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
[TBL] [Abstract][Full Text] [Related]
14. Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.
Archer T; Fowler CJ; Fredriksson A; Lewander T; Magnusson O; Mohringe B; Söderberg U
Br J Pharmacol; 1985 Jul; 85(3):581-90. PubMed ID: 2411326
[TBL] [Abstract][Full Text] [Related]
15. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
16. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
[TBL] [Abstract][Full Text] [Related]
17. Chronic effects of clomipramine and clorgyline on regional levels of brain amines and acid metabolites in rats.
Mousseau DD; Greenshaw AJ
J Neural Transm; 1989; 75(1):73-9. PubMed ID: 2465373
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
19. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
Hársing LG; Vizi ES
Br J Pharmacol; 1984 Nov; 83(3):741-9. PubMed ID: 6439273
[TBL] [Abstract][Full Text] [Related]
20. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
